Systemic BCNU enhances the efficacy of local delivery of a topoisomerase I inhibitor against malignant glioma

By Storm Phillip   Renard Violette   Moriarity John   Tyler Betty   Wilentz Robb   Brem Henry   Weingart Jon  

Cancer Chemotherapy and Pharmacology, Vol. 54, Iss. 4, 2004-10 ,pp. : 361-367

Springer Publishing Company

Access to resources Recommend Favorite

Interstitial Docetaxel (Taxotere), Carmustine and Combined Interstitial Therapy: a Novel Treatment for Experimental Malignant Glioma

By Sampath Prakash   Rhines Laurence   DiMeco Francesco   Tyler Betty   Park Michael   Brem Henry  

Journal of Neuro-Oncology, Vol. 80, Iss. 1, 2006-10 ,pp. : 9-17

Springer Publishing Company

Access to resources Recommend Favorite

Novel drug delivery system using thermoreversible gelation polymer for malignant glioma

By Arai Takao   Joki Tatsuhiro   Akiyama Masaharu   Agawa Miyuki   Mori Yuichi   Yoshioka Hiroshi   Abe Toshiaki  

Journal of Neuro-Oncology, Vol. 77, Iss. 1, 2006-03 ,pp. : 9-15

Springer Publishing Company

Access to resources Recommend Favorite

Clinical Development of Experimental Virus-Mediated Gene Therapy for Malignant Glioma

By  

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 11, Iss. 8, 2011-10 ,pp. : 739-747

Bentham Science Publishers

Access to resources Recommend Favorite

Planning of hyperthermic treatment for malignant glioma using computer simulation

By Uzuka T.   Tanaka R.   Takahashi H.   Kakinuma K.   Matsuda J.   Kato K.  

International Journal of Hyperthermia, Vol. 17, Iss. 2, 2001-03 ,pp. : 114-122

Informa Healthcare

Access to resources Recommend Favorite